This event occurred in (b)(6).Calibration and qc data was requested but not provided.Product labeling states: "the sensitivity of the elecsys anti-sars-cov-2 assay early after infection is unknown.Negative results do not preclude acute sars-cov-2 infection.If acute infection is suspected, direct testing for sars-cov-2 is necessary." based on the available data, a general reagent issue could be excluded.The investigation did not identify a product problem.The cause of the event could not be determined.
|
The initial reporter received questionable elecsys anti-sars-cov-2 results for one patient tested on a cobas 6000 e 601 module serial number (b)(4).On (b)(6) 2020, the patient tested positive for pcr methodology.On (b)(6) 2020, the patient had a blood sample drawn.The customer performed testing with a covid 2 igg and igm rapid test.The manufacturer of the covid 2 igg and igm rapid tests were requested but not provided.The patient¿s rapid test results were igg negative and igm positive.On 25-jun-2020, the blood sample was further tested with the elecsys anti-sars-cov-2 assay and had a result of 0.057 coi non-reactive.The customer performed repeat testing with the covid 2 igg and igm rapid test.The patient¿s rapid test results were igg negative, and the igm positive.
|